Skip to main content
Log in

C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo

  • Scientific Correspondence
  • Published:
Molecular Psychiatry Submit manuscript

A Corrigendum to this article was published on 25 August 2005

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Duan J et al. Hum Mol Genet 2003; 12: 205–216.

  2. Noble EP . Am J Med Genet 2003; 116B: 103–125.

  3. Farde L et al. Synapse 1995; 20 (3): 200–208.

  4. Pohjalainen T et al. Mol Psychiatry 1998; 3: 256–260.

    Article  CAS  Google Scholar 

  5. Hietala J et al. Arch Gen Psychiatry 1994; 51: 116–123.

    Article  CAS  Google Scholar 

  6. Laakso A et al. Pharmacogenetics, (in press)..

  7. Dubertret C et al. Schizophr Res 2004; 67 (1): 75–85.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Hietala.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirvonen, M., Laakso, A., Någren, K. et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9, 1060–1061 (2004). https://doi.org/10.1038/sj.mp.4001561

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001561

  • Springer Nature Limited

This article is cited by

Navigation